Stryker Acquires Cerus Endovascular
May 2, 2023
Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).
- Buyers
- Stryker
- Targets
- Cerus Endovascular Ltd.
- Industry
- Medical Devices
- Location
- England, United Kingdom
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.